OPTIMISATION

On 21 September 2016, the President of the UN General Assembly convened an one-day high-level meeting at the UN Headquarters in New York on “Antimicrobial Resistance“ where all 193 UN member states have agreed to combat the proliferation of drug-resistant infections, estimated to kill more than 700,000 people each year. Current problematic lies in finding innovative solutions to fight bacterial resistance while any novel antibiotic class was discovered in the past 30 years.

With its partner, Carlina Technologies, Atlangram uses the innovative technology of Nano-Encapsulation in Lipid Nano-Capsules (LNCs) for antibacterial agents to improve antibacterial’ efficacy and tolerance.

figure-lnc

This option is clearly a suitable solution to molecules whose development failed due to chemical or pharmacological or toxicological properties.

CONTACT US

 

+33 610 341 744

contact@atlangram.com

 

ATLANGRAM

Nantes Biotech Business

22 Boulevard Benoni GOULLIN

44200 NANTES - FRANCE

Mentions légales

Linkedin